Merck Completes Acquisition of Harpoon Therapeutics, Inc.
https://www.merck.com/news/merck-completes-acquisition-of-harpoon-therapeutics-inc/
WebMar 11, 2024 · Under the terms of the merger agreement, Merck, through a subsidiary, has acquired all outstanding shares of Harpoon. As previously disclosed, this transaction is being accounted for as an asset acquisition. Merck is recording a non-tax deductible charge to R&D expense of approximately $650 million. The impact of the transaction on expected ...
DA: 21 PA: 69 MOZ Rank: 94